# Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma

> **NCT07655570** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 10 (estimated)

## Conditions studied

- Cutaneous Angiosarcoma

## Interventions

- **DRUG:** Ivonescimab

## Key facts

- **NCT ID:** NCT07655570
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-19
- **Primary completion:** 2027-05-11
- **Final completion:** 2029-05-11
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655570, "Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07655570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*